These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 15531494

  • 1. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).
    Geffner M, Lundberg M, Koltowska-Häggström M, Abs R, Verhelst J, Erfurth EM, Kendall-Taylor P, Price DA, Jonsson P, Bakker B.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5435-40. PubMed ID: 15531494
    [Abstract] [Full Text] [Related]

  • 2. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 3. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [Abstract] [Full Text] [Related]

  • 4. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adult height in patients treated for isolated growth hormone deficiency: role of birth weight.
    Di Cesare Merlone A, Bozzola E, Castelnovi C, Chiabotto P, Costante L, De Sanctis L, Tinelli C, Bozzola M.
    Horm Res; 2005 Oct; 63(2):102-6. PubMed ID: 15767761
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data.
    Reinehr T, Lindberg A, Koltowska-Häggström M, Ranke M.
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):721-6. PubMed ID: 24750131
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R, Bakker B, Lundberg M, Doerr HG.
    Pediatr Rehabil; 2006 Nov; 9(2):144-8. PubMed ID: 16449073
    [Abstract] [Full Text] [Related]

  • 13. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
    Darendeliler F, Berberoğlu M, Ocal G, Adiyaman P, Bundak R, Günöz H, Baş F, Darcan S, Gökşen D, Arslanoğlu I, Yildiz M, Ercan O, Ercan G, Ozerkan E, Can S, Böber E, Adal E, Sarikaya S, Dallar Y, Siklar Z, Bircan I, Bideci A, Yüksel B, Büyükgebiz A.
    J Pediatr Endocrinol Metab; 2005 Oct; 18(10):949-54. PubMed ID: 16355808
    [Abstract] [Full Text] [Related]

  • 14. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
    Bakker NE, Lindberg A, Heissler J, Wollmann HA, Camacho-Hübner C, Hokken-Koelega AC, KIGS Steering Committee.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1702-1711. PubMed ID: 28323917
    [Abstract] [Full Text] [Related]

  • 15. Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data.
    Reinehr T, Bechtold-Dalla Pozza S, Bettendorf M, Doerr HG, Gohlke B, Hauffa BP, Kaspers S, Land C, Mehls O, Schwab KO, Stahnke N, Ranke MB, German KIGS Study Board.
    Exp Clin Endocrinol Diabetes; 2011 Oct 01; 119(9):544-8. PubMed ID: 22006181
    [Abstract] [Full Text] [Related]

  • 16. Short Children with CHARGE Syndrome: Do They Benefit from Growth Hormone Therapy?
    Dörr HG, Boguszewski M, Dahlgren J, Dunger D, Geffner ME, Hokken-Koelega AC, Lindberg A, Polak M, Rooman R, KIGS International Board.
    Horm Res Paediatr; 2015 Oct 01; 84(1):49-53. PubMed ID: 26044035
    [Abstract] [Full Text] [Related]

  • 17. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA.
    Horm Res; 2005 Oct 01; 63(1):40-7. PubMed ID: 15627781
    [Abstract] [Full Text] [Related]

  • 18. Growth response, pubertal growth and final height in Greek children with growth hormone (GH) deficiency on long-term GH therapy and factors affecting outcome.
    Karavanaki K, Kontaxaki C, Maniati-Christidi M, Petrou V, Dacou-Voutetakis C.
    J Pediatr Endocrinol Metab; 2001 Apr 01; 14(4):397-405. PubMed ID: 11327373
    [Abstract] [Full Text] [Related]

  • 19. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F, Du Caju MV, Heinrichs C, Maes M, De Schepper J, Craen M, Vanweser K, Malvaux P, Rosenfeld RG.
    J Clin Endocrinol Metab; 1999 May 01; 84(5):1558-61. PubMed ID: 10323379
    [Abstract] [Full Text] [Related]

  • 20. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 May 01; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.